Xavier Duportet is the founder of Eligo Bioscience. Eligo Bioscience has raised $54M in total funding. Latest round: Series B. Based in Paris, France.
Xavier Duportet is the co-founder of Eligo Bioscience, a biotech company established in 2014. He conducted a joint thesis at INRIA and MIT Boston before co-founding Eligo Bioscience. The company focuses on developing sequence-specific antibiotics using reprogrammed viruses to target bacterial resistance and virulence genes.
Full founder directory · Investor directory · Company funding database · Fundraising library